Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Suspected infectious mononucleosis (febrile sore throat, fatigue, lymphadenopathy)

Infectious diseases · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 6 to 8 cases per 1 000 person-years between 15 and 24 years in rich countries [1]

First-line tests

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Negative monospot test and EBV serology: other causes

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (9)
  1. Sylvester JE, Buchanan BK, Silva TW. Infectious Mononucleosis: Rapid Evidence Review. Am Fam Physician. 2023;107(1):71-78.
  2. Lupo J, Truffot A, Andreani J, Habib M, Epaulard O, Morand P, Germi R. Virological markers in Epstein-Barr virus-associated diseases. Viruses. 2023;15(3):656.
  3. Caisse nationale de l’assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 3786, 1009, 1010, 1008 (virus d’Epstein-Barr), 1260 (CMV), 4122 (charge virale VIH).
  4. bpacnz (Nouvelle-Zélande). Sick and tired of being tired and sick: laboratory investigation of glandular fever. Best Tests, octobre 2012.
  5. Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91(6):372-6.
  6. Centers for Disease Control and Prevention (États-Unis). Epstein-Barr Virus and Infectious Mononucleosis: Laboratory Testing. Page revue le 28 septembre 2020.
  7. National Institute for Health and Care Excellence. Sore throat (acute): antimicrobial prescribing. NICE guideline NG84, 26 janvier 2018 : recommandation 1.1.5.
  8. NHS Borders (Écosse). Referral help toolkit : Glandular fever. Right Decisions (outil local de soins primaires), révisé le 18 septembre 2025.
  9. Haut Conseil de la santé publique. Prévention de l'infection à cytomégalovirus chez la femme enceinte et chez le nouveau-né. Rapport, 18 mai 2018.